DK2854765T3 - Farmaceutisk pemetrexed-opløsning - Google Patents
Farmaceutisk pemetrexed-opløsning Download PDFInfo
- Publication number
- DK2854765T3 DK2854765T3 DK13737527.5T DK13737527T DK2854765T3 DK 2854765 T3 DK2854765 T3 DK 2854765T3 DK 13737527 T DK13737527 T DK 13737527T DK 2854765 T3 DK2854765 T3 DK 2854765T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical
- pemetrexed solution
- pemetrexed
- solution
- pharmaceutical pemetrexed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102012010774A DE102012010774A1 (de) | 2012-05-31 | 2012-05-31 | Pharmazeutische Pemetrexed-Lösung |
| PCT/DE2013/000292 WO2013178214A1 (de) | 2012-05-31 | 2013-05-29 | Pharmazeutische pemetrexed-lösung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2854765T3 true DK2854765T3 (da) | 2019-07-01 |
Family
ID=48793847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13737527.5T DK2854765T3 (da) | 2012-05-31 | 2013-05-29 | Farmaceutisk pemetrexed-opløsning |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2854765B1 (da) |
| KR (2) | KR102004341B1 (da) |
| DE (1) | DE102012010774A1 (da) |
| DK (1) | DK2854765T3 (da) |
| ES (1) | ES2731526T3 (da) |
| HR (1) | HRP20191016T1 (da) |
| PL (1) | PL2854765T3 (da) |
| PT (1) | PT2854765T (da) |
| WO (1) | WO2013178214A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101260636B1 (ko) * | 2012-11-29 | 2013-05-13 | 씨제이제일제당 (주) | 안정화된 페메트렉시드 제제 |
| ES2775582T3 (es) | 2014-10-16 | 2020-07-27 | Synthon Bv | Composición farmacéutica líquida que comprende pemetrexed |
| WO2016159684A1 (ko) * | 2015-04-01 | 2016-10-06 | 주식회사 아모레퍼시픽 | 소듐 2-메르캅토에탄 설포네이트를 함유하는 피부 재생 촉진용 조성물 |
| KR101693675B1 (ko) | 2015-12-14 | 2017-01-06 | 주식회사 종근당 | 페메트렉시드 또는 그의 약제학적으로 허용가능한 염을 함유하는 안정화된 약학조성물 |
| US20170239250A1 (en) * | 2016-02-19 | 2017-08-24 | Eagle Pharmaceuticals, Inc. | Pemetrexed formulations |
| KR102040034B1 (ko) | 2017-12-13 | 2019-11-05 | 주식회사 아이큐어비앤피 | 페메트렉시드를 포함하는 경구용 약학 조성물 및 이의 제조방법 |
| EP4046626A1 (de) | 2021-02-21 | 2022-08-24 | STADA Arzneimittel AG | Verwendung einer pemetrexed-konzentratlösung |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200401436T4 (tr) * | 2000-02-04 | 2004-07-21 | Eli Lilly And Company | Monotiyogliserol, L-sistem veya tiyoglikolik asitle birlikte pemetrexed içeren farmasötik bileşim |
| WO2012015810A2 (en) | 2010-07-28 | 2012-02-02 | Eagle Pharmaceuticals, Inc. | Pharmaceutical compositions containing pemetrexed having extended storage stability |
| KR20130122065A (ko) * | 2012-04-30 | 2013-11-07 | 씨제이제일제당 (주) | 페메트렉시드를 함유하는 안정화된 주사용 액상 제제 |
| KR101260636B1 (ko) | 2012-11-29 | 2013-05-13 | 씨제이제일제당 (주) | 안정화된 페메트렉시드 제제 |
-
2012
- 2012-05-31 DE DE102012010774A patent/DE102012010774A1/de not_active Ceased
-
2013
- 2013-05-29 EP EP13737527.5A patent/EP2854765B1/de active Active
- 2013-05-29 PL PL13737527T patent/PL2854765T3/pl unknown
- 2013-05-29 ES ES13737527T patent/ES2731526T3/es active Active
- 2013-05-29 WO PCT/DE2013/000292 patent/WO2013178214A1/de active Application Filing
- 2013-05-29 DK DK13737527.5T patent/DK2854765T3/da active
- 2013-05-29 PT PT13737527T patent/PT2854765T/pt unknown
- 2013-05-29 KR KR1020177021453A patent/KR102004341B1/ko active IP Right Grant
- 2013-05-29 KR KR1020147031312A patent/KR101843613B1/ko active IP Right Grant
-
2019
- 2019-06-04 HR HRP20191016TT patent/HRP20191016T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102004341B1 (ko) | 2019-07-26 |
| KR20150020266A (ko) | 2015-02-25 |
| ES2731526T3 (es) | 2019-11-15 |
| KR101843613B1 (ko) | 2018-03-29 |
| WO2013178214A1 (de) | 2013-12-05 |
| PT2854765T (pt) | 2019-06-25 |
| EP2854765B1 (de) | 2019-03-27 |
| HRP20191016T1 (hr) | 2019-08-23 |
| EP2854765A1 (de) | 2015-04-08 |
| KR20170091778A (ko) | 2017-08-09 |
| DE102012010774A1 (de) | 2013-12-05 |
| PL2854765T3 (pl) | 2019-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2922877T3 (da) | Forbedrede peptidlægemidler | |
| CL2012002088S1 (es) | Dispensador | |
| DK2897594T3 (da) | Farmaceutisk sammensætning | |
| CL2014003283A1 (es) | Formulación farmacéutica. | |
| DK2854765T3 (da) | Farmaceutisk pemetrexed-opløsning | |
| BR302013002456S1 (pt) | Dispensador | |
| BR302012003979S1 (pt) | Configuração aplicada em fármaco | |
| FR2997638B1 (fr) | Cristallisoir | |
| ECSP12011630A (es) | Formulación farmacéutica | |
| UA25445S (uk) | Стелаж | |
| FR2986420B1 (fr) | Pillulier | |
| FI9626U1 (fi) | Moduulirakenteinen pylväs | |
| UA25454S (uk) | Флакон для лікарських засобів | |
| UA25455S (uk) | Флакон для лікарських засобів | |
| UA24159S (uk) | Флакон для лікарських засобів | |
| UA25275S (uk) | Флакон для лікарських засобів | |
| UA24201S (uk) | Флакон для лікарських засобів | |
| UA24158S (uk) | Флакон для лікарських засобів | |
| TH148762B (th) | อนุพันธ์ของพิร์โรลิดีน-3-อิลแอซีติก แอซิด | |
| TH1401000958B (th) | ขวด | |
| UA23396S (uk) | Пляшка | |
| UA23394S (uk) | Пляшка | |
| UA23395S (uk) | Пляшка | |
| TH1401007265A (th) | ขวด | |
| UA23325S (uk) | Пляшка |